Indian company J.B. Chemicals & Pharmaceuticals has announced the launch of its new Femident division, which will focus on gynecology and dental products in through its domestic formulations business.
The new division has more than 100 medical representatives and 15 products, some of which are first of its kind in its respective segment, according to the company.
J.B. Chemicals said it plans to increase its medical representatives in this division to 300 over the next two years as it continues to focus on growing its share in the U.S., Europe, Australia, and Brazil.
